What if you invested $1000 in MCRB on Jan 1, 2020?
Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.
Historical Annual Returns
Over the past 11 years, Seres Therapeutics, Inc. has delivered an average annual return of 19.5%. The stock peaked in 2020 with a massive +631.3% gain, while investors faced a downturn in 2023 (-74.1%). Overall, the stock finished in the green 2 times out of 11 years.
Avg Return
+19.5%
Win Rate
18%
2W - 9L
Best
+631.3%
2020
Worst
-74.1%
2023
Performance Consistency
About Seres Therapeutics, Inc.
Visit Website ↗Seres Therapeutics is a commercial-stage biotechnology company focused on revolutionizing the treatment of a wide range of diseases by modulating the function of the human microbiome.
Key Business Segments
Therapeutics
Development of microbiome therapeutics.
Key Innovations
- ✓Ecobiotic® drugs
- ✓VOWST™ (first FDA-approved oral microbiome therapeutic)
Historical Milestones
Founded by Flagship Pioneering.
IPO on NASDAQ.
FDA approval of VOWST.